Newsroom · Sioux Falls

What Happens to Your Medicare Drug Coverage 36 Months After a Kidney Transplant

A federal clock most people never hear about quietly ends free-standing Medicare coverage for kidney transplant recipients — but one narrow benefit can keep the drugs that protect your new kidney covered.

Big Sioux Benefits Data Desk

Published November 11, 2026 · 16 min read · Sourced from CMS, SSA, and UNOS

Yes — if your only path to Medicare was End-Stage Renal Disease (ESRD), your Medicare eligibility is scheduled to end exactly 36 months after a successful kidney transplant, and a separate federal benefit called Part B-ID is the one tool built specifically to keep your anti-rejection drugs covered after that date. Nobody mails you a reminder six months out the way a Medicare Advantage plan mails an Annual Notice of Change. The 36-month date just arrives, and if you haven't planned for it, the first you hear about it can be a termination notice or a pharmacy counter that suddenly wants full price for a drug that keeps your transplanted kidney alive. This guide walks through why the clock exists, exactly what Part B-ID covers and costs in 2026, who's excluded from it, how to actually enroll, and what it looks like for someone living in the Sioux Falls area.

Every figure below comes from CMS's own Part B-ID program pages, CMS's 2026 Medicare cost fact sheet, the Social Security Administration's program manual, and UNOS's own transplant data — all fetched and confirmed this week. Nothing here is pulled from memory or an AI summary.

Does the 36-month clock apply to you?

It applies if End-Stage Renal Disease (ESRD) — permanent kidney failure requiring dialysis or a transplant — is the only reason you qualify for Medicare. That's different from qualifying by age or by disability, where a kidney transplant doesn't change your Medicare eligibility at all. If ESRD is your only path in, CMS's own Part B-ID benefit page states the rule plainly: that Medicare eligibility "ends 36 months after a kidney transplant." It isn't a warning about losing some extra benefit. It's the end of Medicare itself, for people in that specific situation.

Source: CMS — Medicare Part B Immunosuppressive Drug (Part B-ID) Benefit.

If you have Medicare for a different reason too — you're 65 or older, or you qualify through a disability unrelated to your kidneys — this 36-month rule doesn't end your Medicare. It only applies to the narrower group whose Medicare exists because of ESRD and nothing else. If you're not sure which category you're in, your transplant center's social worker or financial counselor can tell you from your own enrollment record, and so can we.

Why Medicare's ESRD coverage has an expiration date

Medicare's ESRD rules were built around dialysis and transplant as a medical crisis with an endpoint, not an open-ended condition. A successful transplant is treated, by the rule itself, as resolving the ESRD that made you eligible in the first place — even though you'll take immunosuppressive drugs for the rest of the transplant's life to prevent your body from rejecting it. The 36-month window was Congress's way of giving that recovery period medical and financial room to run before Medicare eligibility based on ESRD alone comes to a close.

That gap — a drug you'll need indefinitely, paired with coverage that was only ever designed to be temporary — is exactly the problem Congress addressed when it created the Part B Immunosuppressive Drug benefit. Applications opened October 1, 2022, with coverage starting as early as January 1, 2023, per CMS. It's a comparatively new benefit, which is part of why so few people seem to know it exists until they're the ones who need it.

Source: CMS — Part B-ID benefit, provider & enrollment detail.

Before this benefit existed, the 36-month cutoff was simply the end of the story for anyone in this situation — transplant physician groups had pushed for a fix for roughly two decades before Congress finally passed it, per the American Society of Transplantation's own account of the effort. That history matters for one practical reason: this is still a relatively young benefit, implemented starting in 2023, so it hasn't yet had time to become common knowledge the way AEP or the Part D deductible has. If your transplant center, your pharmacist, or a family member hasn't mentioned it to you by name, that's not unusual — it just means someone has to go looking for it, which is the point of this guide.

Source: American Society of Transplantation — on the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act becoming law.

What the Part B-ID benefit actually covers

Part B-ID is deliberately narrow. CMS describes it as covering "continuous immunosuppressive drugs that are medically necessary to prevent or treat rejection of a transplanted organ or tissue" — nothing more. It explicitly does not cover any other Part A, B, or D service, supply, or drug, including antibiotics, vitamins, or medications unrelated to organ rejection. If you were picturing a scaled-down version of full Medicare, that's the wrong mental model. It's closer to a single-purpose prescription benefit that happens to run through Part B.

Source: CMS — Medicare Part B Immunosuppressive Drug (Part B-ID) Benefit.

That narrowness matters in practice. If you develop an unrelated health problem after your ESRD-based Medicare ends — a broken wrist, a case of pneumonia, a routine colonoscopy — Part B-ID doesn't pay a cent toward any of it. It only ever touches the drugs protecting your transplanted kidney. For everything else, you'd need your own separate coverage: an employer plan, a Marketplace plan, or Medicare through a different path entirely, such as turning 65 or qualifying by a different disability.

What it costs in 2026, in real numbers

Three numbers determine your actual cost, and all three are published by CMS for 2026. The Part B-ID premium is $121.60 a month — confirmed on both CMS's own 2026 Medicare Parts A & B Premiums and Deductibles fact sheet and, independently, on the Social Security Administration's own program operations manual. After that premium, the standard $283 annual Part B deductible applies before coverage pays anything, and once that's met, you pay 20% coinsurance on the Medicare-approved amount for your drugs — the same cost-sharing structure as ordinary Part B.

Sources: CMS — 2026 Medicare Parts A & B Premiums and Deductibles (Fact Sheet, Nov. 14, 2025); Social Security Administration — POMS TN 63, Part B Immunosuppressive Drug Premium; CMS — Medicare costs at a glance.

Sources: CMS — 2026 Medicare Parts A & B Premiums and Deductibles (Fact Sheet, Nov. 14, 2025); UNOS — U.S. kidney transplant totals, 2025.

Do the math on just the two fixed numbers CMS publishes, and the floor of what this benefit costs becomes concrete: $121.60 a month times 12 months is $1,459.20 a year in premium alone, before a single refill is even counted. Add the $283 deductible, and you're at roughly $1,742.20 guaranteed before coverage pays its first dollar toward a drug — and that's before the 20% coinsurance on every refill after that. It isn't free, and CMS doesn't advertise it as free. What it is — compared to paying full retail for anti-rejection drugs with no coverage at all — is the difference between a predictable monthly bill and an unpredictable one.

27,573 kidney transplants happened nationwide in 2025 alone, per UNOS, which gives some sense of scale: a meaningful number of people are moving through this same 36-month window every single year, mostly without anyone flagging it for them in advance. If you're the adult child helping a parent who had a transplant years ago, this is exactly the kind of federal deadline that's easy to lose track of — it doesn't arrive with a colorful envelope every September the way a Medicare Advantage renewal does, and it only comes around once, not annually. Putting the date on a shared calendar now, well before it arrives, is the single most useful thing a family member can do here.

Who qualifies, and the other-coverage trap

Two eligibility rules matter more than anything else here, and missing either one is the most common way people get caught off guard. First, you must have had Part A at the time of your kidney transplant — per CMS, "you must be enrolled in at least Part A in the month you have a kidney transplant to have Medicare Part B ever pay for your immunosuppressive drugs." If you didn't have Part A then, this specific benefit isn't available to you later, no matter when you apply.

Source: CMS — Part B-ID benefit, provider & enrollment detail.

Second — and this is the trap — you're excluded if you already have, or expect to have, other coverage for immunosuppressive drugs. CMS lists the disqualifying categories specifically: a group or individual health plan, including a Marketplace plan; TRICARE; Medicaid or CHIP coverage that includes immunosuppressive drugs; and VA coverage or even VA eligibility for these drugs. That last point surprises people — you don't have to be actively using VA coverage to be excluded, just eligible for it. The logic is straightforward: Part B-ID exists to fill a specific gap, not to duplicate coverage you already have another way.

Source: CMS — Medicare Part B Immunosuppressive Drug (Part B-ID) Benefit.

How to actually enroll

Five steps, roughly in order, whether your 36-month date is already behind you or still months away:

One more practical note: you can enroll in or disenroll from Part B-ID at any time, without a late penalty, per CMS's own enrollment rules for this benefit. That's genuinely different from how most Medicare enrollment windows work, and it means there's no single hard deadline you have to hit on the exact 36-month date — but there's also no reason to put off applying once you know you'll need it, since every month without it is a month of full-price drugs.

Source: CMS — Part B-ID benefit, provider & enrollment detail.

What this looks like in Sioux Falls

Kidney failure isn't rare here. South Dakota's adult chronic kidney disease prevalence sits at 4.0%, based on 2024 survey data compiled by America's Health Rankings from the CDC's own Behavioral Risk Factor Surveillance System — a reminder that transplant recipients navigating this 36-month rule are a real, ongoing part of the local Medicare population, not a rare edge case.

Source: America's Health Rankings — Chronic kidney disease, South Dakota, 2024 data.

Locally, Avera Transplant Institute in Sioux Falls runs a kidney transplant referral and evaluation program, so a transplant recipient living in or near Sioux Falls may have had their surgery and follow-up care coordinated right here rather than at a distant center. If that's your situation, your own transplant team is the most reliable source for your exact transplant date and your Part A enrollment status at the time — the two facts that start this whole calculation. If your transplant happened at a different center entirely, that's fine too; the 36-month rule and the Part B-ID benefit work the same way regardless of where your surgery took place.

It's worth saying plainly: this isn't a Sioux Falls-specific rule, or a South Dakota one. The 36-month clock and the Part B-ID benefit work identically whether you live two blocks from the Big Sioux River or two states away. What's local is the help available while you sort through it — a neighbor who's been through it, a transplant coordinator who knows the paperwork, or a local advisor who can sit down with you rather than leave you on hold with a national call center.

One more local wrinkle worth naming: if you're weighing Medicare Advantage instead of sticking with Original Medicare plus Part B-ID, your immunosuppressive drug coverage runs through that plan's own formulary and tiers rather than through this specific federal benefit. Whether that's better or worse depends entirely on your own drug list and the plan — not something either path is automatically better at. We compare Medicare Advantage options against Part B-ID's known costs as part of a full coverage review, among the carriers we offer in the Sioux Falls area.

What happens if you miss the window

Missing your own planning for the 36-month date doesn't mean your ESRD-based Medicare keeps going past it — it ends on schedule regardless of whether you planned for it. What actually changes is whether you have anything lined up to replace it. If you haven't applied for Part B-ID and you have no other coverage for these drugs, you can still apply after the fact; CMS doesn't impose a late penalty on this specific benefit. But every month between your Medicare ending and your Part B-ID coverage actually starting is a month you'd be paying full retail price for anti-rejection medication with no coverage cushioning the cost — the exact gap this benefit was built to close, sitting open while you work out the paperwork.

Source: CMS — Part B-ID benefit, provider & enrollment detail.

The more serious risk isn't the paperwork delay — it's not finding out about the 36-month rule at all until a termination letter arrives, with no plan for what replaces that coverage. A transplant that succeeded medically can still turn into a financial emergency if the drugs that keep it working suddenly cost full price. That's the entire reason this guide exists: so the 36-month date is something you're tracking on your own calendar, not something that finds you first.

How we help

Big Sioux Benefits runs drug cost reviews and annual coverage reviews for Medicare beneficiaries in the Sioux Falls area, and that includes situations like this one — mapping your 36-month date, checking whether Part B-ID or a Medicare Advantage plan fits your specific drug list better, and making sure you know which path applies to you well before the date arrives. We don't sell the Part B-ID benefit itself — it's a federal program applied for through Social Security — but we can help you understand what it means for your coverage and your budget, and compare it against the Medicare Advantage and Medigap options we offer locally. That conversation costs nothing — carriers pay the agent, not the other way around.

Big Sioux Benefits is a licensed independent insurance agency and is not connected with or endorsed by the United States government or the federal Medicare program. We do not offer every plan available in your area; any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options.

What to watch going into 2027

1. Mark your own 36-month date now if you've had a kidney transplant and ESRD is your only path to Medicare — don't wait for a termination notice to find it.
2. Confirm your Part A enrollment status at the time of transplant with your transplant center's billing office; it's the single fact that decides whether Part B-ID is available to you at all.
3. Rule out other coverage before you apply — a Marketplace plan, Medicaid, TRICARE, or even VA eligibility can disqualify you, and it's better to know that before the 36-month date than after.
4. Re-check the premium every year. The $121.60 figure is specific to 2026; CMS republishes Part B-ID's premium alongside the standard Part B premium each fall, usually in November.
5. If you're also weighing Medicare Advantage, compare its drug formulary against Part B-ID's known cost structure before assuming either one is automatically the better deal for your situation.

How we know this: Every figure on this page comes from CMS's own Part B Immunosuppressive Drug Benefit program pages, CMS's 2026 Medicare Parts A & B Premiums and Deductibles fact sheet, the Social Security Administration's program operations manual, CMS's own published Medicare cost pages, UNOS's own 2025 transplant data, and America's Health Rankings' compilation of CDC survey data — all read this week. This is education, not advice; confirm your own transplant date, Part A enrollment history, and eligibility with Social Security and a licensed agent. We take no payment from any carrier to feature a plan. Built with Strategic AI Architects.